Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026

Same author

Persistence of PET scan positivity after chemoimmunotherapy for DLBCL.

Blood advances·2026

Same author

A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML.

American journal of hematology·2025

Same author

Primum succurrere; first hasten to help.

The oncologist·2025

Same author

Academic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery.

Leukemia & lymphoma·2025

Same author

Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative Review.

JAMA oncology·2025

Search research articles

Related Experiment Video

Updated: May 20, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Non-Hodgkin lymphoma.

Kate R Shankland¹, James O Armitage, Barry W Hancock

¹Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK. kate.shankland@sth.nhs.uk

Lancet (London, England)

|July 28, 2012

Summary

Lymphomas are immune system cancers. This review covers advances in understanding non-Hodgkin lymphoma biology and new treatments for these common, diverse malignancies.

Area of Science:

Oncology
Immunology
Hematology

Background:

Lymphomas are solid tumors originating from the immune system.
Hodgkin's lymphoma comprises 10% of lymphomas; non-Hodgkin lymphomas (NHL) constitute the remaining 90%.
NHL presents with diverse histology and clinical features, complicating diagnosis.

Purpose of the Study:

To review recent advancements in understanding lymphoma biology.
To discuss novel therapeutic strategies for various lymphoma subtypes.
To highlight the importance of timely diagnosis for effective treatment.

Main Methods:

Review of current scientific literature on lymphoma.
Analysis of recent clinical trial data for novel therapies.
Synthesis of biological insights into lymphoma pathogenesis.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Main Results:

Significant progress in deciphering the biological underpinnings of lymphoma.
Emergence of new and effective treatment options for many lymphoma subtypes.
Recognition of the heterogeneity within non-Hodgkin lymphomas.

Conclusions:

Advances in understanding lymphoma biology are driving therapeutic innovation.
Effective and curative treatments are available for numerous lymphoma subtypes.
Early diagnosis remains critical for successful management of these immune system malignancies.